Lab Analysis for Supplements, Parapharmaceuticals & Herbal Products
GMP-compliant analytical testing and CoA preparation in French and English — for EU, FDA, and Health Canada regulatory submissions.
Care Europe provides GMP-compliant analytical reports and laboratory analysis coordination for food supplements, nutraceuticals, parapharmaceuticals, and herbal products — formatted in French and English for EU, FDA, and Health Canada submissions.
Many EU regulatory submissions — particularly for the French market — require documentation in French. Care Europe bridges the gap between North American laboratory analysis and EU regulatory requirements by providing bilingual analytical reports, coordinating with ISO 17025 accredited partner laboratories, and preparing documentation packages for EU, FDA, and Health Canada submissions.
Bilingual Analytical Reporting
Care Europe translates and adapts North American laboratory reports (Certificates of Analysis, method summaries, validation reports) into French-language formats accepted by EU regulatory authorities. We ensure that analytical terminology, units of measurement, and regulatory references are correctly adapted for EU submissions. Our bilingual reports are prepared by regulatory professionals familiar with both North American and EU analytical standards.
ISO 17025 Aligned Methodology Documentation
EU regulatory submissions require analytical data generated using validated, ISO 17025 aligned methodologies. Care Europe reviews your existing analytical data for EU acceptability, identifies gaps in method validation documentation, and prepares supplementary technical files where needed. We coordinate with accredited partner laboratories in France and the EU when additional testing is required to meet EU regulatory standards.
French Market Entry Documentation
The French market has specific requirements beyond the EU-wide regulations. ANSES (Agence nationale de sécurité sanitaire) oversees food supplement notifications in France, and ANSM (Agence nationale de sécurité du médicament) regulates cosmetics and pharmaceuticals. Care Europe prepares complete French-language dossiers for ANSES and ANSM submissions, including analytical summaries, safety data, and product information in the required French format.
Services & Methods Included
- ✓ Certificate of Analysis (CoA) French translation and adaptation
- ✓ Method validation summary in French
- ✓ Analytical data review for EU acceptability
- ✓ ANSES food supplement notification dossier
- ✓ ANSM cosmetic product notification support
- ✓ Bilingual safety data sheet preparation
- ✓ French-language Product Information File (PIF)
- ✓ ISO 17025 gap analysis for EU submissions
- ✓ Partner laboratory coordination (France/EU)
- ✓ Regulatory terminology adaptation EN→FR
Regulatory Standards & Compliance
- French regulatory standards
- EU GMP (ISO 22716)
- ISO 17025 aligned
- ANSES notification requirements
- ANSM regulatory framework
Industries We Serve
- North American Exporters
- Supplement Brands
- Cosmetic Companies
- French Market Entry Clients
- Pharmaceutical Companies
- Contract Manufacturers
Request a Consultation
Tell us about your product and regulatory challenge. We'll respond within 24 hours with an honest assessment and clear next step.
Get a Free Assessment →Frequently Asked Questions
Why do I need French-language lab reports for EU submissions?
While EU regulations are harmonised, French regulatory authorities (ANSES for food supplements, ANSM for cosmetics) often require or strongly prefer French-language documentation. For French market entry specifically, notification dossiers submitted to ANSES must include French-language analytical summaries and product information. Care Europe ensures your documentation meets these language requirements.
Can you work with my existing North American lab reports?
Yes. Care Europe reviews your existing CoAs and analytical reports from North American ISO 17025 accredited laboratories, adapts them to EU regulatory formats, and translates them into French where required. In most cases, you do not need to retest your products — we work with your existing data to prepare EU-compliant documentation.
Are your French-language reports accepted by French regulatory authorities?
Care Europe is registered and operating in France, which provides credibility with French regulatory authorities. Our French-language reports are prepared by regulatory professionals with direct experience in ANSES and ANSM submissions. We work within the established regulatory frameworks to ensure your documentation meets authority requirements.
Why brands choose Care Europe for french lab analysis
Registered in France
EU regulatory partner with legal standing
Bilingual EN/FR
Reports in English and French
NA–EU Bridge
We understand both regulatory worlds
Related articles
When Your Cosmetic Becomes a Medicinal Product: The Borderline Classification Risk Under EU Regulation 1223/2009
High-concentration actives can trigger ANSM reclassification of your cosmetic as a medicinal product. What's at stake — and how to assess the risk before EU market entry.
EU Cosmetics Regulation 1223/2009The EU Cosmetic Product Safety Report: What Regulation (EC) No 1223/2009 Requires in Part A and Part B
A technical breakdown of the CPSR under Regulation EC No 1223/2009 — what Part A must document and what Part B must conclude for EU market compliance.
Herbal & Supplement Testing (rare in Europe)Why European Regulators Are Scrutinising Ashwagandha — and What Supplement Brands Must Test Before Going to Market
ANSES flagged 27 adverse event reports linked to ashwagandha; Denmark restricted high-dose products. What EU supplement brands must test before launch.
EU Cosmetics Regulation 1223/2009Cosmetics Vigilance Reporting in France: What Article 23 of Regulation 1223/2009 Actually Demands
Article 23 of Regulation 1223/2009 requires SUE reporting within 20 days. What France's ANSM expects from cosmetic brands — and where most fall short.
Ready to start your EU french lab analysis?
Tell us about your product and target EU markets. We'll respond within 24 hours with a regulatory assessment and next steps.
Get a Regulatory Quote →